Production-Ready AI in Pharma: What’s Working, What’s Not, and What’s Next

🚀 AI in Pharma: Navigating the Future
AI investment in the pharmaceutical industry is skyrocketing, yet production-grade results continue to elude many. According to MIT, a staggering 95% of enterprise GenAI pilots deliver zero measurable ROI. Additionally, fewer than 20% of organizations see strong returns on their investments, and only 12% of healthcare leaders deem today’s AI as reliable for clinical applications. This discrepancy between expectation and reality is costing the industry billions.

Join Roche, CMC AI, and Celestial Systems for an intimate, invitation-only session in South San Francisco where senior leaders from pharma and biotech will engage in meaningful discussions about the real requirements needed to transition AI from mere experimentation to full-scale production in regulated environments.

What to Expect

Three concise presentations will cover:

• 📊 Enterprise-Grade AI in Life Sciences — Why most pharma AI pilots fail to make it to production and how strategic platform choices can enhance success rates.
• ⚙️ AI-Driven CMC Process Optimization — Exploring how AI is revolutionizing Chemistry, Manufacturing, and Controls, from formulation design to regulatory submissions.
• 🔗 From AI Strategy to Production Deployment — Insights on bridging the gap between promising pilots and scalable, governed AI systems essential for regulated industries.

A moderated Q&A session will allow for deeper exploration of these topics and encourage open dialogue among participants. This is a must-attend event for anyone working to ensure that AI delivers tangible results in pharma and biotech, whether in R&D, operations, or strategic planning. Expect a small group atmosphere, candid conversations, and sufficient time to connect with peers before concluding your evening.

Our Esteemed Speakers:

• Alok Singh — Global AI Product Manager, Roche
  Alok leads Roche’s largest clinical data and content generation program, boasting over 15 years of AI and machine learning experience.
• Sunil Shah, Ph.D., RAC — CEO & Co-Founder, CMC AI
  With over 35 years of CMC experience, Dr. Shah co-founded CMC AI to enhance the efficiency of CMC processes throughout the drug development lifecycle.
• Rahul Raina — VP of Business Development, Celestial Systems
  Rahul has steered growth at Celestial Systems for over 15 years, guiding organizations through digital transformation.
• Moderator: Shri Shrivas — Director, Informatics Product Management, Genentech
  With 25 years of experience in healthcare IT, Shri drives innovation at Genentech across therapeutic areas.

The Venue

The session will take place at the Hilton Garden Inn San Francisco Airport North, conveniently located near the Genentech campus and directly across from the shuttle pickup at Poletti Way, ensuring easy access for attendees.

About Us

• Genentech — A Roche Group member and biotech pioneer since 1976.
• Roche — Leading advancements in personalized medicine for over 125 years.
• CMC AI — Innovating AI-based platforms to streamline CMC processes in drug development.
• Celestial Systems — Empowering organizations through responsible AI solutions since 2001.

✨ Space is limited for this invite-only session designed for senior leaders in Pharma and Biotech. Complimentary refreshments and a networking reception will be provided!

🔗 Reserve Your Spot Here